Evidence that the Moderna vaccine produces a higher level of antibodies than the Pfizer vaccine might give it an edge as a booster, some scientists say. Yet some people experience more side effects with Moderna, albeit mostly moderate ones, such as fatigue, muscle aches and chills. And the antibody difference between Pfizer and Moderna isn’t huge. “From the data we’ve got, Moderna is doing a touch bit better,” says Deepta Bhattacharya, PhD, a professor of immunobiology at the College of Medicine – Tucson. “We’re not talking orders of magnitude.”

The College of Medicine – Phoenix is one of 11 medical schools in a new anti-racism initiative. The Anti-Racist Transformation in Medical Education initiative at the Icahn School of Medicine at Mount Sinai seeks to use a formal change management process developed at New York City-based Mount Sinai to address deeply entrenched racism and bias.

Data from an ongoing research study at the University of Arizona Health Sciences show that first responders – including firefighters, law enforcement, correctional officers and emergency medical service providers – are at elevated risk of COVID-19 infection compared with other essential workers and frontline health care personnel.

Proceeds from the event will support melanoma research, community outreach, education and patient care in Arizona.

Telemundo Arizona: David Garcia, PhD, associate professor of health promotion sciences and Edgar Villavicencio, a research specialist from the Mel and Enid Zuckerman College of Public Health, discuss the consequences of obesity and the connection to culture, habits and lifestyle.

Regardless of legal status or nationality, the different Mexican consulate offices in Arizona offer free health services. “When you immigrate to the U.S., access is a challenge for many people. The health systems are different in both countries and therefore we need to educate the migrant population and connect them with health services,” said Cecilia Rosales, MD, MS, associate dean of community engagement and outreach at the Mel and Enid Zuckerman College of Public Health.

The relatively low number of West Nile cases has been a roadblock for development of a vaccine. In Phase III clinical trials, a significant number of individuals has to be infected and enrolled in order for a vaccine or treatment to demonstrate efficacy. Only a proven effective vaccine will be approved for use in humans, explained Deepta Bhattacharya, PhD, a professor of immunobiology at the College of Medicine – Phoenix. “That was one of the reasons why the SARS-CoV-2 vaccines were able to be deployed so quickly: at the time Pfizer and Moderna were testing the vaccine, there was a ton of community spread,” Dr. Bhattacharya said.

Many factors weaken the aging immune system. But vaccines—and booster doses—do offer protection from hospitalization and death. Experts say they still don’t have an adequate explanation for why older people were more susceptible to COVID-19 even before vaccines were available. “It’s just one of the great mysteries of the virus,” says Deepta Bhattacharya, PhD, professor of immunobiology at the College of Medicine – Tucson.

Nicola Finley, MD, a board-certified internal medicine physician and adjunct faculty member at the Mel and Enid Zuckerman College of Public Health, will lead a panel on how the pandemic exposed inequities in both health care and wellness and how that will be tackled in the future.